FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/12/2022
Back to search
Official data from USPTO
MYRIO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MYRIO THERAPEUTICS
ST13
US500000079313379Class
1, 5, 42
Filing
79313379
Registration
6810858
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
12/12/2022
Trademark type
Word
Nice classes
1, 5, 42
Filing date
03/19/2021
Registration date
08/09/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/09/2022
Last transaction
08/09/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
AU
Examiner
HACK, ANDREA R
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Myrio Therapeutics Pty Ltd
Representatives
Brendan J. Hughes Cooley LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Antibodies for scientific purposesother than for medical or veterinary use; biological preparations for laboratory purposes; biological preparations for use in science and industryfor use in the pharmaceutical industry; chemical preparations for use in science; chemical preparations for use in the pharmaceutical industry
Class 5
Therapeutic antibodies for the treatment of autoimmune diseasesoncological diseasesviruses; biological preparations for pharmaceutical purposes for the treatment of autoimmune diseasesoncological diseasesviruses; pharmaceutical preparations for treating autoimmune diseasesoncological diseasesviruses; pharmaceutical compositions for treating autoimmune diseasesoncological diseasesvirus
Class 42
Scientific laboratory services for scientific research or analysis; laboratory research in the field of biology; scientific research
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/18/2022
FIMP
FINAL DISPOSITION PROCESSED
11/18/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/09/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/09/2022
GPNX
NOTIFICATION PROCESSED BY IB
05/24/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/24/2022
PUBO
PUBLISHED FOR OPPOSITION
05/24/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/04/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/04/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/21/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/20/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/19/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/19/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/11/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/11/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/11/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/11/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/11/2022
RFNT
REFUSAL PROCESSED BY IB
12/13/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/23/2021
RFRR
REFUSAL PROCESSED BY MPU
11/23/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/26/2021
CNRT
NON-FINAL ACTION WRITTEN
10/25/2021
DOCK
ASSIGNED TO EXAMINER
10/24/2021
MAFR
APPLICATION FILING RECEIPT MAILED
06/26/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/22/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/17/2021
Continuous trademark protection
Get notified about every new filing that threatens MYRIO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.